• [[ Whitepaper ]] Connecting With Rare Disease Patient Communities: Patient Advocates

    laureng Whitepapers April 19, 2018
  • [[Whitepaper ]] Disruptive Innovation in Rare Disease Markets

    laureng Whitepapers April 19, 2018
  • Choosing the Right Channel Strategy for Specialty Product Success

    Karina Kusova Clinical Development, Market Access, Orphan Drug Congress, Supply Chain & Manufacturing, Uncategorized, Whitepapers May 3, 2017
  • [Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies

    Karina Kusova Clinical Development, Orphan Drug Congress, Uncategorized, Whitepapers April 10, 2017
  • [[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches

    Karina Kusova Clinical Development, Featured on App, Orphan Drug Congress, Uncategorized, Whitepapers April 6, 2017
  • What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!)

    Karina Kusova Advocacy, Clinical Development, Market Access, Orphan Drug Congress, Orphan Drugs Live October 10, 2016

Subscribe to Total Orphan Drugs

Strategy and innovation in the orphan drugs and rare diseases industry
Navigation
  • Development
  • Regulation
  • Advocacy
  • Market Access
  • Partnering & Investment
  • Whitepapers
  • Events
    • USA
  • Search
Uncategorized

Uncategorized

View Post

[[eBook]] Life-changing LAUNCH

In Featured on App, Orphan Drug Congress, Supply Chain & Manufacturing, Uncategorized, Whitepapers by Karina KusovaMarch 20, 2017Leave a Comment

Manufacturer perspectives on maximizing success for orphan drug commercialization You’re a manufacturer of orphan drugs, which means the new product you’ve spent years developing has …

View Post

Chris Garabedian – Orphan Drug Congress Interview Part 1

In Uncategorized by Karina KusovaMarch 17, 2017Leave a Comment

Andre Singer (Project Director- World Orphan Drug Congress USA) and Chris Garabedian(Former CEO of Sarepta Therapeutics) discuss the current state of affairs in the Orphan …

[[WHITEPAPER]] Global Rare Disease Drug Development: Understanding and mitigating its complexities

In Uncategorized by Karina KusovaMarch 16, 2017Leave a Comment

This insight brief examines the varied definitions and regulatory pathways for rare disease therapies. The authors describe QuintilesIMS’s proven patient centric approaches to study planning, …

View Post

What’s the outlook for the Orphan drug market in 2022?

In Clinical Development, Featured on App, Orphan Drug Congress, Reports, Uncategorized, Whitepapers by Karina KusovaFebruary 27, 2017Leave a Comment

By Lisa Urquhart, EP Vantage Editor and Report Contributor Annual “EvaluatePharma® Orphan Drug 2017 Report” sees continued growth for orphan drugs, approximately double overall prescription …

View Post

Towards a New Way of Evaluating Orphan Drugs at CADTH

In Uncategorized by Karina KusovaFebruary 23, 2017Leave a Comment

McKesson Canada is the leading provider of market access services connecting patients to orphan drugs and other drug therapies within the Canadian health care market. …

View Post

[Whitepaper] It is never too early to think “drug product”

In Orphan Drug Congress, Uncategorized, Whitepapers by Freya SmaleMarch 23, 2016Leave a Comment

Drug product will follow you all the way through the clinical trials and into the commercial supply to healthcare systems and the patients. Download the whitepaper …

View Post

Positive Collaboration – Alström Syndrome UK

In Advocacy, Orphan Drug Congress, Partnering & Investment, Uncategorized by Freya SmaleFebruary 24, 2016Leave a Comment

Kerry Leeson-Beevers, National Development Manager at Alström Syndrome UK joined us at World Orphan Drug Congress Europe 2015 to provide insight into the role how positive collaboration …

View Post

World Orphan Drug Congress LIVE: Pitch and Partner Sessions

In Orphan Drugs Live, Partnering & Investment, Uncategorized by Freya SmaleApril 24, 2015Leave a Comment

Pitch & Partner has been quite beneficial for both sides. We’ve heard wonderful pitches and saw plenty of interests. Here are some of the pitches …

  • Page 2 of 19
  • ←
  • 1
  • 2
  • 3
  • ...
  • 19
  • →

Categories

  • Advocacy
  • Clinical Development
  • Featured on App
  • Market Access
  • Orphan Drug Congress
  • Orphan Drugs Live
  • Partnering & Investment
  • Press Release
  • Regulation & Government
  • Reports
  • Supply Chain & Manufacturing
  • Uncategorized
  • Whitepapers
Toggle the Widgetbar
World Orphan Drug Congress USA
  • Home
  • About Us/Advertise